TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer.

Peter Schmid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.